Evidence map›Paper›PMID 38081870›Full record

ArticleScientific reports2023

Identifying primary aldosteronism patients who require adrenal venous sampling: a multi-center study.

Takumi Kitamoto, Tsuyoshi Idé, Yuta Tezuka, Norio Wada, Yui Shibayama, Yuya Tsurutani, Tomoko Takiguchi, Kosuke Inoue, Sachiko Suematsu, Kei Omata and 7 more

Abstract readMulticenter Study
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Takumi Kitamoto *Endocrinology and Diabetes Center, Yokohama Rosai Hospital, Yokohama, 2220036, Japan. t.kitamoto@chiba-u.jp.ORCID 0000-0002-9457-267X
Tsuyoshi Idé *IBM Research, T. J. Watson Research Center, Yorktown Heights, NY, 10598, USA.
Yuta TezukaDepartment of Diabetes, Metabolism, and Endocrinology, Tohoku University Hospital, Sendai, 9808574, Japan.
Norio WadaDepartment of Diabetes and Endocrinology, Sapporo City General Hospital, Sapporo, 0608604, Japan.
Yui ShibayamaDepartment of Diabetes and Endocrinology, Sapporo City General Hospital, Sapporo, 0608604, Japan.
Yuya TsurutaniEndocrinology and Diabetes Center, Yokohama Rosai Hospital, Yokohama, 2220036, Japan.
Tomoko TakiguchiEndocrinology and Diabetes Center, Yokohama Rosai Hospital, Yokohama, 2220036, Japan.
Kosuke InoueDepartment of Social Epidemiology, Graduate School of Medicine, Kyoto University, Kyoto, 6048135, Japan.
Sachiko SuematsuEndocrinology and Diabetes Center, Yokohama Rosai Hospital, Yokohama, 2220036, Japan.
Kei OmataDepartment of Diabetes, Metabolism, and Endocrinology, Tohoku University Hospital, Sendai, 9808574, Japan.
Yoshikiyo OnoDepartment of Diabetes, Metabolism, and Endocrinology, Tohoku University Hospital, Sendai, 9808574, Japan.
Ryo MorimotoDivision of Nephrology, Rheumatology, and Endocrinology, Tohoku University Graduate School of Medicine, Sendai, 9808574, Japan.
Yuto YamazakiDepartment of Pathology, Tohoku University Graduate School of Medicine, Sendai, 9808575, Japan.
Jun SaitoEndocrinology and Diabetes Center, Yokohama Rosai Hospital, Yokohama, 2220036, Japan.
Hironobu SasanoDepartment of Pathology, Tohoku University Graduate School of Medicine, Sendai, 9808575, Japan.
Fumitoshi SatohDivision of Nephrology, Rheumatology, and Endocrinology, Tohoku University Graduate School of Medicine, Sendai, 9808574, Japan.
Tetsuo NishikawaEndocrinology and Diabetes Center, Yokohama Rosai Hospital, Yokohama, 2220036, Japan.

Funding

JSPS KAKENHI JP22K16422Ministry of Health, Labor, and Welfare, Japan 20FC1020Ministry of Health, Labor, and Welfare, Japan 23FC1041
6 · The paper itself

Abstract

Adrenal venous sampling (AVS) is crucial for subtyping primary aldosteronism (PA) to explore the possibility of curing hypertension. Because AVS availability is limited, efforts have been made to develop strategies to bypass it. However, it has so far proven unsuccessful in applying clinical practice, partly due to heterogeneity and missing values of the cohorts. For this purpose, we retrospectively assessed 210 PA cases from three institutions where segment-selective AVS, which is more accurate and sensitive for detecting PA cases with surgical indications, was available. A machine learning-based classification model featuring a new cross-center domain adaptation capability was developed. The model identified 102 patients with PA who benefited from surgery in the present cohort. A new data imputation technique was used to address cross-center heterogeneity, making a common prediction model applicable across multiple cohorts. Logistic regression demonstrated higher accuracy than Random Forest and Deep Learning [(0.89, 0.86) vs. (0.84, 0.84), (0.82, 0.84) for surgical or medical indications in terms of f-score]. A derived integrated flowchart revealed that 35.2% of PA cases required AVS with 94.1% accuracy. The present model enabled us to reduce the burden of AVS on patients who would benefit the most.

Indexed as

HyperaldosteronismAdrenal GlandsAldosteroneHumansRetrospective StudiesVenae CavaeAldosterone

Identifiers

PMID38081870
PMCPMC10713522

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.